Cascara Sagrada Bark Extract (Cascaroside A)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Cascara Sagrada Bark Extract (Cascaroside A).

Cascara sagrada functions as a stimulant laxative by utilizing anthraquinone glycosides that undergo bacterial hydrolysis in the colon to induce peristalsis and increase electrolyte secretion.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

10887612

Molecular Weight

1025.3 g/mol

XLogP3 (Lipophilicity)

9.9

IUPAC Name

22-N-cyclohexyl-13-N-(2-methylpropyl)-4-N-pentyl-31-N-(2-phenylethyl)-1,3,5,7,10,12,14,16,19,21,23,25,28,30,32,34,39,42,45,48-icosazanonacyclo[32.2.2.27,10.216,19.225,28.12,6.111,15.120,24.129,33]octatetraconta-2(48),3,5,11(45),12,14,20,22,24(42),29,31,33(39)-dodecaene-4,13,22,31-tetramine

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Ginger Root for [Mitigating abdominal cramping and smooth muscle spasms via prokinetic modulation]
Psyllium Husk for [Combining stimulant effects with bulk-forming fiber to optimize colonic transit time]

Biological Formulation Enhancers

Bifidobacterium species for [Providing the beta-glucosidase enzymes necessary to hydrolyze cascarosides into active emodin aglycones]
Magnesium Citrate for [Enhancing osmotic pressure to complement stimulant-induced peristalsis]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Cascara Sagrada Bark Extract (Cascaroside A) across standard consumer modalities.

💊 Standard Capsules

The extract's hygroscopic nature requires moisture-resistant HPMC shells and desiccants to prevent clumping and maintain biomarker stability.

🍬 Gummy & Pectin Formats

The intense bitterness of anthraquinone glycosides necessitates complex flavor masking and may interfere with the cross-linking of pectin-based gelling agents.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for stimulant laxation significantly exceeds the standard 20-50mg payload capacity of thin-film oral delivery systems.

For Brand Founders

Formulate with Cascara Sagrada Bark Extract (Cascaroside A)

Ready to launch a product featuring Cascara Sagrada Bark Extract (Cascaroside A)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Cascara Sagrada Bark Extract (Cascaroside A) Bioavailability

Need absolute proof that your Cascara Sagrada Bark Extract (Cascaroside A) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Cascara Sagrada Bark Extract (Cascaroside A) Degradation Testing

Is your Cascara Sagrada Bark Extract (Cascaroside A) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation